Cookies

Like most websites The Translational Scientist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Neuroscience

Research Field Neuroscience

The Pitter-Patter of Tiny Diagnoses

A simple yet accurate model could help streamline ROP screening

Research Field Neuroscience

The Matchmaker

| Paul Ursell

Introducing the easy-to-use system that offers patients lower risks of complications – regardless of surgeon experience

Research Field Neuroscience

Searching for Schizophrenia

| Michael Schubert

Researchers identified the cell types associated with schizophrenia mutations

Research Field Drug discovery

Bringing Alzheimer’s in from the Cold

| Roisin McGuigan

With big pharma seemingly pulling out of the field, what hope remains for novel treatments for Alzheimer’s disease?

Research Field Informatics

AI Picks Parkinson’s

| James Strachan

Could artificial intelligence help repurpose old drugs for suffers of the degenerative disorder?

Research Field Biomedical engineering

Hot Off the Press

| Roisin McGuigan

What if, instead of waiting for a donor cornea to become available, you could just print one?

Research Field Cell & gene therapy

Fresher and CRISPR

The promise of genome editing is tempered for genetically heterogeneous diseases – introducing a new approach for rhodopsin-dependent retinitis pigmentosa.

Research Field Neuroscience

VEGF Veteran

| Napoleone Ferrara

Napoleone Ferrara, Distinguished Adjunct Professor of Ophthalmology, UC San Diego School of Medicine, California, USA.

Research Field Cell & gene therapy

The Best Treatment

| Ruth Steer

Is gene therapy the answer to an untreatable form of macular degeneration?

Research Field Cell & gene therapy

The Secret is the Secretions

| Nicolas Sohl

Stem cells hold great promise, but is it the cells we really need?

Register to The Translational Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register